Paclitaxel micelle formulation

N/A

Report date: 2023/08/15 20:01:07

Base Information

Drug NamePaclitaxel micelle formulation
Drug Alias NameMacromolecular micelle paclitaxelPolymeric micelle paclitaxelNK-105
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin polymerisation inhibitorsTubulin polymerisation promotersPlatelet-derived growth factor receptor inhibitors +[5] 
TargetsTubulinPlatelet-derived growth factor receptorApoptosis regulator Bcl-2
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNippon Kayaku Co LtdNanocarrier Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNippon Kayaku Co Ltd
Active IndicationsN/A
Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A